GFUS
Basic information
Region (hg38): 8:143612618-143618048
Previous symbols: [ "TSTA3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GFUS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 36 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 10 | 10 | ||||
Total | 0 | 0 | 36 | 2 | 11 |
Variants in GFUS
This is a list of pathogenic ClinVar variants found in the GFUS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-143612720-G-C | Benign (May 15, 2021) | |||
8-143612883-G-A | Benign (May 26, 2021) | |||
8-143612918-G-C | not specified | Uncertain significance (Mar 07, 2023) | ||
8-143612927-C-G | not specified | Uncertain significance (Nov 14, 2023) | ||
8-143612965-G-A | not specified | Uncertain significance (Jun 06, 2023) | ||
8-143613006-C-T | Benign (May 17, 2021) | |||
8-143613148-G-A | Benign (May 23, 2021) | |||
8-143613208-G-C | not specified | Uncertain significance (Oct 03, 2022) | ||
8-143613216-C-T | not specified | Likely benign (Aug 16, 2022) | ||
8-143613258-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
8-143613288-G-A | not specified | Uncertain significance (Dec 06, 2023) | ||
8-143613329-C-A | Benign (May 17, 2021) | |||
8-143613396-C-T | Benign (May 15, 2021) | |||
8-143613537-T-C | not specified | Uncertain significance (Oct 02, 2023) | ||
8-143613538-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
8-143613559-C-A | Uncertain significance (Jul 01, 2023) | |||
8-143613561-G-A | not specified | Uncertain significance (Apr 04, 2023) | ||
8-143613562-C-T | not specified | Uncertain significance (Feb 07, 2025) | ||
8-143613565-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
8-143613598-C-T | not specified | Uncertain significance (Feb 18, 2025) | ||
8-143613600-C-T | not specified | Uncertain significance (Jun 11, 2021) | ||
8-143613697-A-G | Benign (May 15, 2021) | |||
8-143613787-G-A | not specified | Uncertain significance (Jul 31, 2023) | ||
8-143614033-T-C | Benign (May 15, 2021) | |||
8-143614168-G-A | not specified | Uncertain significance (Nov 23, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GFUS | protein_coding | protein_coding | ENST00000425753 | 10 | 5431 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.68e-7 | 0.654 | 125686 | 0 | 56 | 125742 | 0.000223 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.198 | 197 | 205 | 0.961 | 0.0000128 | 2116 |
Missense in Polyphen | 55 | 62.807 | 0.8757 | 680 | ||
Synonymous | -1.98 | 113 | 89.2 | 1.27 | 0.00000658 | 615 |
Loss of Function | 1.15 | 13 | 18.3 | 0.710 | 9.52e-7 | 191 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00142 | 0.00139 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000116 | 0.000114 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000295 | 0.000294 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the two-step NADP-dependent conversion of GDP- 4-dehydro-6-deoxy-D-mannose to GDP-fucose, involving an epimerase and a reductase reaction. {ECO:0000269|PubMed:8910301}.;
- Pathway
- Fructose and mannose metabolism - Homo sapiens (human);Amino sugar and nucleotide sugar metabolism - Homo sapiens (human);Fructose intolerance, hereditary;Fructose and Mannose Degradation;Fructosuria;Fructose Mannose metabolism;Post-translational protein modification;Metabolism of proteins;GDP-fucose biosynthesis;Synthesis of substrates in N-glycan biosythesis;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;GDP-L-fucose biosynthesis I (from GDP-D-mannose)
(Consensus)
Recessive Scores
- pRec
- 0.159
Intolerance Scores
- loftool
- 0.247
- rvis_EVS
- -1.09
- rvis_percentile_EVS
- 7.05
Haploinsufficiency Scores
- pHI
- 0.108
- hipred
- N
- hipred_score
- 0.322
- ghis
- 0.525
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.151
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tsta3
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; digestive/alimentary phenotype;
Gene ontology
- Biological process
- T cell mediated cytotoxicity;leukocyte cell-cell adhesion;GDP-mannose metabolic process;electron transport chain;'de novo' GDP-L-fucose biosynthetic process
- Cellular component
- cytosol;extracellular exosome
- Molecular function
- electron transfer activity;isomerase activity;GDP-4-dehydro-D-rhamnose reductase activity;identical protein binding;GDP-mannose 3,5-epimerase activity;GDP-L-fucose synthase activity;coenzyme binding